Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 29 articles PubMed · modèle : gemma4:31b
Résumé
White willow (Salix alba) bark is a traditional remedy used for thousands of years as an anti-inflammatory, antipyretic, and analgesic [PMID:25997859, PMID:35203473].
Contexte
White willow (Salix alba) is a plant whose bark has been used since ancient times, with therapeutic potential noted in Egypt as early as 1534 BC [PMID:35203473]. It served as the natural precursor to the development of aspirin [PMID:14592543, PMID:22117784].
Usages traditionnels
Traditionally used to treat fever, inflammatory conditions, rheumatism, and pain [PMID:30000964, PMID:11192932, PMID:34944032].
Composés actifs
The bark contains salicylic acid and its derivative salicin [PMID:30000964, PMID:40702178]. Other phenolic compounds identified include salidroside, saligenin, tremulodin, salicoylsalicin, salicortin, and tremulacin [PMID:31906808].
Mécanisme d'action
Willow bark extracts inhibit the cyclooxygenase (COX) enzyme, preventing the formation of prostaglandins that cause inflammation, pain, and fever [PMID:14592543]. In vitro studies also indicate down-regulation of inflammatory mediators tumor necrosis factor-α and nuclear factor-kappa B [PMID:25997859]. Salicin may also inhibit angiogenesis by blocking ROS-ERK pathways [PMID:24535656] and activate the bitter taste receptor TAS2R16 [PMID:40261795, PMID:26096905].
Preuves cliniques
Preuve AArthritis
Meta-analysis of RCTs showed significant differences in pain relief and improvement in physical status compared to placebo [PMID:37895439].
Preuve CChronic lower back pain and osteoarthritis
A small number of clinical studies support the use of willow bark extracts for these conditions [PMID:25997859].
Sécurité et effets indésirables
Common adverse effects are gastrointestinal, with some reports of allergic reactions [PMID:3160435 la]. There is a risk of increased bleeding in vulnerable individuals [PMID:31604354]. In vitro studies on human cultured leukocytes noted a genotoxic response [PMID:31906808, PMID:34674609].
Grossesse et allaitement
Willow bark is best avoided during breastfeeding because salicylic acid is excreted into breastmilk, and this excretion increases as maternal dosage increases [PMID:30000964]. Salicylates also cross the placenta and are eliminated slowly in newborns [PMID:31604354].
Interactions médicamenteuses
Concurrent use with other salicylate-containing medicines increases the risk of bleeding and other salicylate-related adverse effects [PMID:31604354].
Synthèse des preuves
Evidence for pain relief in arthritis is supported by a meta-analysis of RCTs (Level A). Other clinical applications for back pain and osteoarthritis are supported by a limited number of studies (Level C), while much of the remaining data is based on historical use or in vitro/animal models.
Sources PubMed
- 1.PMID: 14592543 (2003) — The mechanism of action of aspirin. · Thrombosis research
- 2.PMID: 25997859 (2015) — Efficacy and Safety of White Willow Bark (Salix alba) Extracts. · Phytotherapy research : PTR
- 3.PMID: 30000964 (2006) — The first 3500 years of aspirin history from its roots - A concise summary. · Vascular pharmacology
- 4.PMID: 40702178 (2025) — Three-step biosynthesis of salicylic acid from benzoyl-CoA in plants. · Nature
- 5.PMID: 34944032 (2021) — From NSAIDs to Glucocorticoids and Beyond. · Cells